January 05, 2012
Takeda Pharmaceutical Co. Ltd. and Watson Pharmaceuticals Inc. sued Mylan Inc. in New York on Tuesday, alleging Mylan infringed several patents when it sought regulatory approval for a generic version of the diabetes treatment Actoplus Met XR.